UBS Group’s BIOMED REALTY TRUST INC BMR Stock Holding History

UBS Group’s Portfolio BMR Stock Details BMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-459,708	Closed	-$10.9M	–	8771
2015 Q4	$10.9M	Buy	459,708 +175,567	+62%	+$4.08M	0.01%	1347
2015 Q3	$5.68M	Sell	284,141 -74,764	-21%	-$1.5M	﹤0.01%	1818
2015 Q2	$6.94M	Sell	358,905 -46,962	-12%	-$973K	﹤0.01%	1777
2015 Q1	$9.2M	Buy	405,867 +180,214	+80%	+$4.14M	0.01%	1545
2014 Q4	$4.86M	Buy	+225,653	New	+$4.81M	﹤0.01%	2113

Other funds holding BMR

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

MAM

Mizuho Asset Management Tokyo, Japan $462M AUM 15.39% 1-Year Est. Return

Kimelman & Baird New York $1.22B AUM 11.47% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

UBS Group's BMR Position: Q1 2016 in Review

UBS Group sold out of BIOMED REALTY TRUST INC (BMR) in Q1 2016, closing a stake of 459,708 shares — an estimated $10.9M sold.

UBS Group first reported a position in BMR in Q4 2014 and held it in 5 quarters. The position peaked at $10.9M in Q4 2015. 4 funds tracked by Wall St. Rank hold BMR as of Q1 2016.

UBS Group reported no remaining BIOMED REALTY TRUST INC position as of Q1 2016 after selling out during the quarter.
UBS Group sold 459,708 BIOMED REALTY TRUST INC shares in Q1 2016, an estimated $10.9M.
UBS Group first reported a position in BIOMED REALTY TRUST INC in Q4 2014 and held it in 5 quarters.
UBS Group's BIOMED REALTY TRUST INC position peaked at $10.9M in Q4 2015.
4 funds tracked by Wall St. Rank held BIOMED REALTY TRUST INC as of Q1 2016.

Based on UBS Group's 13F filing for Q1 2016, filed 12 May 2016.